Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q3 EPS of ($0.43), $0.47 better than the analyst estimate of ($0.90).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.